脳血管障害の治療の進歩

「I. 脳梗塞の急性再開通療法」「1. 機械的血栓回収療法前の血栓溶解薬前投与の意義」2020年のDIRECT-MT(Direct Intraarterial thrombectomy in order to Revascularize acute ischemic stroke patients with large vessel occlusion Efficiently in Chinese Tertiary hospitals : a Multicenter randomized clinical Trial)に引き続き, DEVT(Direct endovascular thromb...

Full description

Saved in:
Bibliographic Details
Published in神経治療学 Vol. 39; no. 5; pp. 749 - 755
Main Author 平野, 照之
Format Journal Article
LanguageJapanese
Published 日本神経治療学会 2022
Subjects
direct thrombectomy
dual antiplatelet therapy (DAPT)
embolic stroke of undetermined source (ESUS)
tenecteplase
thrombosis with thrombocytopenia syndrome (TTS)
Online AccessGet full text
ISSN0916-8443
2189-7824
DOI10.15082/jsnt.39.5_749

Cover

More Information
Summary:「I. 脳梗塞の急性再開通療法」「1. 機械的血栓回収療法前の血栓溶解薬前投与の意義」2020年のDIRECT-MT(Direct Intraarterial thrombectomy in order to Revascularize acute ischemic stroke patients with large vessel occlusion Efficiently in Chinese Tertiary hospitals : a Multicenter randomized clinical Trial)に引き続き, DEVT(Direct endovascular thrombectomy vs combined IVT and endovascular thrombectomy for patients with acute Large Vessel Occlusion in the anterior circulation), SKIP(Randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion), MR CLEAN-NOIV (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands - NOIV)の最終結果が論文発表され, SWIFT-DIRECT, DIRECT-SAFEも主要国際学会で結果が開示(論文発表は2022年)された.
ISSN:0916-8443
2189-7824
DOI:10.15082/jsnt.39.5_749